PDL Biopharma, Inc. is 10% Owner at Evofem Biosciences, Inc. (EVFM). They have made 2 open-market trades across 2 companies since 2019, most recently 2020-10-01.
CIK 0000882104
2 open-market purchases totalling $60.2M since 2019, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.